Similar articles for PMID: 32303497

Year	Number of Results
2015	1
2020	36
2021	6
2022	1

1

Chloroquine and COVID-19 - a potential game changer?

Sturrock BR, Chevassut TJ. Sturrock BR, et al. Clin Med (Lond). 2020 Apr 17;20(3):278-81. doi: 10.7861/clinmed.2020-0129. Online ahead of print. Clin Med (Lond). 2020. PMID: 32303497 Free PMC article.

2

Emergency Authorization of Chloroquine and Hydroxychloroquine for Treatment of COVID-19.

Piszczatoski CR, Powell J. Piszczatoski CR, et al. Ann Pharmacother. 2020 Aug;54(8):827-831. doi: 10.1177/1060028020925558. Epub 2020 May 9. Ann Pharmacother. 2020. PMID: 32389025

3

A systematic review of the prophylactic role of chloroquine and hydroxychloroquine in coronavirus disease-19 (COVID-19).

Shah S, Das S, Jain A, Misra DP, Negi VS. Shah S, et al. Int J Rheum Dis. 2020 May;23(5):613-619. doi: 10.1111/1756-185X.13842. Epub 2020 Apr 27. Int J Rheum Dis. 2020. PMID: 32281213 Free PMC article.

4

A Review of SARS-CoV-2 and the Ongoing Clinical Trials.

Tu YF, Chien CS, Yarmishyn AA, Lin YY, Luo YH, Lin YT, Lai WY, Yang DM, Chou SJ, Yang YP, Wang ML, Chiou SH. Tu YF, et al. Int J Mol Sci. 2020 Apr 10;21(7):2657. doi: 10.3390/ijms21072657. Int J Mol Sci. 2020. PMID: 32290293 Free PMC article. Review.

5

Improving the efficacy of Chloroquine and Hydroxychloroquine against SARS-CoV-2 may require Zinc additives - A better synergy for future COVID-19 clinical trials.

Shittu MO, Afolami OI. Shittu MO, et al. Infez Med. 2020 Ahead of print Jun 1;28(2):192-197. Infez Med. 2020. PMID: 32335560 Free article. Review.

6

The origin, transmission and clinical therapies on coronavirus disease 2019 (COVID-19) outbreak - an update on the status.

Guo YR, Cao QD, Hong ZS, Tan YY, Chen SD, Jin HJ, Tan KS, Wang DY, Yan Y. Guo YR, et al. Mil Med Res. 2020 Mar 13;7(1):11. doi: 10.1186/s40779-020-00240-0. Mil Med Res. 2020. PMID: 32169119 Free PMC article. Review.

7

Hydroxychloroquine for COVID-19: What is our Current State of Knowledge?

Udwadia ZF, Malu KN, Rana D, Joshi SR. Udwadia ZF, et al. J Assoc Physicians India. 2020 Jun;68(6):48-52. J Assoc Physicians India. 2020. PMID: 32610879 Review.

8

The novel zoonotic COVID-19 pandemic: An expected global health concern.

Contini C, Di Nuzzo M, Barp N, Bonazza A, De Giorgio R, Tognon M, Rubino S. Contini C, et al. J Infect Dev Ctries. 2020 Mar 31;14(3):254-264. doi: 10.3855/jidc.12671. J Infect Dev Ctries. 2020. PMID: 32235085 Free article.

9

Chloroquine and hydroxychloroquine in the context of COVID-19.

Shukla AM, Archibald LK, Wagle Shukla A, Mehta HJ, Cherabuddi K. Shukla AM, et al. Drugs Context. 2020 Apr 28;9:2020-4-5. doi: 10.7573/dic.2020-4-5. eCollection 2020. Drugs Context. 2020. PMID: 32373183 Free PMC article. Review.

10

Current Status of Epidemiology, Diagnosis, Therapeutics, and Vaccines for Novel Coronavirus Disease 2019 (COVID-19).

Ahn DG, Shin HJ, Kim MH, Lee S, Kim HS, Myoung J, Kim BT, Kim SJ. Ahn DG, et al. J Microbiol Biotechnol. 2020 Mar 28;30(3):313-324. doi: 10.4014/jmb.2003.03011. J Microbiol Biotechnol. 2020. PMID: 32238757 Free article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed